![](/img/cover-not-exists.png)
447 Evaluation of percutaneous ablation treatments of hepatocellular carcinoma (HCC) as a risk factor for neoplastic recurrence in patients who underwent liver transplant (LT)
V.G. Mirante, M. Pompili, G. Rondinara, D. Forti, G. Rossi, L.R. Fassati, S. Agnes, M. Castagneto, G. Pelecca, G. Gasbarrini, G.L. RapacciniVolume:
38
Year:
2003
Language:
english
DOI:
10.1016/s0270-9139(03)80490-1
File:
PDF, 270 KB
english, 2003